Orbimed Advisors - VERONA PHARMA PLC ownership

VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 39 filers reported holding VERONA PHARMA PLC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of VERONA PHARMA PLC
ValueSharesWeighting
Q3 2023$61,577,781
-22.9%
3,777,7780.0%1.31%
-9.6%
Q2 2023$79,862,227
-6.7%
3,777,778
-11.3%
1.45%
-13.9%
Q1 2023$85,554,675
-28.4%
4,260,691
-6.8%
1.68%
-26.5%
Q4 2022$119,473,912
+105.3%
4,572,289
-19.7%
2.29%
+111.7%
Q3 2022$58,201,000
+143.9%
5,694,8410.0%1.08%
+150.0%
Q2 2022$23,861,000
-16.0%
5,694,8410.0%0.43%
-6.3%
Q1 2022$28,417,000
-25.7%
5,694,8410.0%0.46%
-6.3%
Q4 2021$38,269,000
+22.6%
5,694,8410.0%0.49%
+43.4%
Q3 2021$31,208,000
-16.2%
5,694,8410.0%0.34%
-9.0%
Q2 2021$37,244,000
-21.8%
5,694,8410.0%0.38%
-15.3%
Q1 2021$47,609,000
+19.4%
5,694,8410.0%0.44%
+27.5%
Q4 2020$39,864,000
+12.2%
5,694,8410.0%0.35%
-21.9%
Q3 2020$35,536,000
+507.2%
5,694,841
+355.4%
0.45%
+445.1%
Q2 2020$5,852,000
+13.6%
1,250,3960.0%0.08%
-5.7%
Q1 2020$5,152,000
-28.3%
1,250,3960.0%0.09%
-15.5%
Q4 2019$7,190,000
+25.8%
1,250,3960.0%0.10%
-4.6%
Q3 2019$5,714,000
-10.4%
1,250,3960.0%0.11%
+9.1%
Q2 2019$6,377,000
-21.5%
1,250,3960.0%0.10%
-21.4%
Q1 2019$8,128,000
-32.6%
1,250,3960.0%0.13%
-43.5%
Q4 2018$12,066,000
-22.9%
1,250,3960.0%0.22%
+18.6%
Q3 2018$15,642,000
-8.4%
1,250,3960.0%0.19%
-7.8%
Q2 2018$17,080,000
-31.7%
1,250,3960.0%0.20%
-34.2%
Q1 2018$25,008,000
+68.5%
1,250,3960.0%0.31%
+64.9%
Q4 2017$14,843,000
+45.1%
1,250,396
+87.6%
0.19%
+91.8%
Q3 2017$10,233,000
+31.7%
666,6660.0%0.10%
+21.0%
Q2 2017$7,770,000666,6660.08%
Other shareholders
VERONA PHARMA PLC shareholders Q1 2021
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,111,112$4,656,00016.89%
Aisling Capital Management LP 1,332,485$5,583,0003.98%
Abingworth LLP 2,457,500$10,174,0003.26%
Samsara BioCapital, LLC 1,111,112$4,656,0001.24%
Vivo Capital, LLC 2,749,918$11,522,0001.16%
NEA Management Company, LLC 5,108,563$21,405,0001.10%
Fairmount Funds Management LLC 926,602$3,882,0000.89%
RA Capital Management 5,100,000$21,369,0000.57%
Orbimed Advisors 5,694,841$23,861,0000.43%
Perceptive Advisors 2,915,146$12,214,0000.38%
View complete list of VERONA PHARMA PLC shareholders